对比
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 vs 3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
比较妊娠期雄激素药物相关的XX胎儿发育影响与一种罕见的内在激素处理异常。异常表现本身不是诊断，需临床医生解释。
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
A condition caused when a pregnant person takes hormone medications containing androgens, affecting fetal development. The fetus has XX chromosomes. Stopping the offending agent is key, with specialist care for affected infants.
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
A rare condition affecting how certain hormones are processed in the body, which can influence sexual development. Treatment may involve hormone therapy and specialist care.
6 个对比维度
Onset
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Variable
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
0-16
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
severe
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Chronic
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
No
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
reproductive
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
endocrine
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
endocrine
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
endocrine
Different category
结论
46-xx-disorder-of-sex-development-induced-by-exogenous-maternal-derived-androgen-C5679874 and 3-oxo-5-alpha-steroid-delta-4-dehydrogenase-deficiency-C0268297 differ in severity
关键鉴别要点
在床旁或检查过程中最能可靠区分两种疾病的发现。
| 特征 | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297 | 鉴别力 |
|---|---|---|---|
| 生殖器发育 | XX胎儿可能出现与雄激素相关的非典型生殖器发育。 | 性发育可能受影响，但具体表现尚未明确。 | Moderate |
| 暴露史 | 与妊娠期使用含雄激素药物有关。 | 来源描述并不要求母体药物暴露。 | High |
| 染色体背景 | 来源明确为XX染色体。 | 核型未说明，需要确认。 | High |
何时更支持某种疾病
选择 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 的情况
有妊娠期雄激素药物暴露且婴儿为XX
符合所述外源性病因。
High
生殖器表现异常但未证实内在酶病
暴露史是主要区分依据。
Moderate
暴露仍可停止
来源指出停用相关药物是关键。
High
选择 3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297 的情况
性发育改变但无明确外源性雄激素
来源将其描述为内在激素处理问题。
Moderate
专科怀疑雄激素代谢紊乱
名称提示酶缺乏，但仍需确认。
Moderate
考虑激素治疗
来源称治疗可能包括激素治疗和专科照护。
Low
关键检查差异
| 检查 | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297 | 解读 |
|---|---|---|---|
| 核型分析 | 概念指定为XX。 | 提供资料未确定。 | 未检测前不能推断右侧核型。 |
| 用药与暴露回顾 | 母体含雄激素药物是核心。 | 不要求此类暴露。 | 阳性史支持左侧解释，但不能排除其他情况。 |
| 激素检查 | 可能反映外源暴露时间和类型，无给定界值。 | 可能提示激素处理异常，具体模式未明确。 | 结果需专科解释，单独不能诊断。 |
预后对比
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
- 转归
- 资料标为重度且慢性，但个体结局未明确。
- 因素
- 暴露时间、是否停药及婴儿表现可能相关。
3 Oxo 5 Alpha Steroid Delta 4 Dehydrogenase Deficiency C0268297
- 转归
- 资料标为中度且慢性，没有量化结局。
- 因素
- 激素处理异常程度及专科治疗反应可能相关。
时间范围: 左侧起病不定，右侧列为0–16岁。
未提供患病率、死亡率或确切预后。
并发症对比
| 并发症 | 表现 |
|---|---|
| 非典型生殖器发育 | 可能继发于产前雄激素暴露。 可能由激素处理紊乱引起。 仅凭外观不能确定病因。 |
| 专科照护需求 | 强调婴儿评估并停止持续暴露。 可能需要内分泌随访及激素治疗。 具体干预和剂量未在此确定。 |
| 心理社会负担 | 家庭可能面临病因和发育不确定性。 慢性罕见病可能需要反复咨询。 影响因人而异，不能仅凭严重程度推断。 |
患者教育要点
- High病因
左侧与母体雄激素药物有关；右侧涉及体内激素处理。
- High检查
异常结果或外观本身不是最终诊断，需要临床评估。
- Medium照护
两者都可能需要专科随访；药物调整或激素治疗应个体化。